vialaudit
BPC-157·INDIANA·LAST CHECKED 1 NOV 2026

Is BPC-157 legal in Indiana?

CAVEATS APPLY

Since 1 Jul 2026 Indiana law (IC 16-42-22.5) bars compounding from research-grade or veterinary-grade bulk ingredients outside an IRB-approved study and requires an FDA-registered source with a certificate of analysis. From 1 Jan 2027 medical spas must register with the state medical board. This matters if FDA later allows pharmacies to compound BPC-157: in Indiana the ingredient could not be research grade. Federally: Not as a drug. BPC-157 has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Under an interim HHS policy of 28 October 2026, a licensed pharmacy may compound it against a prescription, by set routes and under strict conditions, without federal enforcement. That policy does not cover research-use-only vials sold online.

CATEGORY · NO APPROVAL

Full status breakdown

FEDERAL · STATE · SPORT-BODY

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA interim category: Nominated but withdrawn (off Category 2, not eligible)
503A Bulks List: pcac recommended
HHS interim policy (Oct 28, 2026): no enforcement against licensed 503A compounding with a prescription · routes: subcutaneous, intramuscular, oral, topical (acetate) · FEDERAL REGISTER ↗
Still not on the 503A Bulks List and not an approved drug. Removed from Category 2 on 15 Apr 2026. On 23 Jul 2026 the PCAC recommended it for the Bulks List (ulcerative colitis). On 28 Oct 2026 HHS issued an interim 'Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances' (Federal Register 30 Oct 2026, 91 FR 68526). HHS says it does not intend to take enforcement action against a state-licensed pharmacy, Federal facility or licensed physician compounding BPC-157 against a patient-specific prescription, limited to subcutaneous, intramuscular, oral, topical, as a single ingredient, from API made by an FDA-registered facility with a full certificate of analysis. The Federal Register notice calls the policy a draft that is not binding; comments close 13 Nov 2026 (docket HHS-OASH-2026-0496). It does not cover 503B outsourcing facilities or research-use-only vials sold online.
PCAC review history
  • Jul 23, 2026 · recommended · 8 yes, 6 no, 1 abstention (law-firm reports; FDA has posted no tally) · SOURCE ↗
FDA Warning Letters
  • Jun 12, 2023 — Warrior Labz SARMs (cited: bpc-157, tb-500) · LETTER ↗
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: RUO label has been repeatedly rejected by FDA in warning letters when human-use intent is evident. The Warrior Labz case progressed to a criminal conviction.
Personal possession: Not federally scheduled; possession is not federally criminalized. Customs interdiction of imported peptide vials is common per FDA Import Alerts.

Indiana — state-specific

compounding restriction · Indiana

Since 1 Jul 2026 Indiana law (IC 16-42-22.5) bars compounding from research-grade or veterinary-grade bulk ingredients outside an IRB-approved study and requires an FDA-registered source with a certificate of analysis. From 1 Jan 2027 medical spas must register with the state medical board. This matters if FDA later allows pharmacies to compound BPC-157: in Indiana the ingredient could not be research grade.

Sport-body status

WADA 2026
prohibited · class S0 · in and out of competition
Named as an S0 example on the 2026 List and again on the 2027 List (in force 1 Jan 2027). Prohibited at all times.
USADA
NCAA
unknown

What we couldn’t verify

Also known as

5 ALIASES

BPC-157 is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Body Protection Compound 157
  • BPC
  • PL-14736
  • Bepecin
  • Pentadecapeptide BPC 157

Related

FOLLOW-ONS

BPC-157: US status, sources and what changed

Other states with a rule that names BPC-157: Ohio. Everywhere else, federal law applies.

THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH